Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Perez

Showing results (41-50 of 134) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 7, 2009
Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib; synergistic activity in human non-small cell lung cancer cell lines and xenograft modelsYi-He Ling, Miguel Aracil, José Jimeno, et al.
Clinical Lung Cancer|November 5, 2015
Toxicity and Pharmacokinetic Studies of Aerosolized Clinical Grade AzacitidineXuan Qiu, Yuanxin Liang, Rani S Sellers, et al.
Molecular Pharmacology|August 16, 2002
Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell linesYi-He Ling, Jian-Dong Jiang, James F Holland, et al.
Oncology (Williston Park, N.Y.)|December 25, 2007
Clinical presentation and pathophysiology of EGFRI dermatologic toxicitiesEdith P Mitchell, Roman Perez-Soler, Eric Van Cutsem, et al.
International Journal of Molecular Sciences|August 26, 2017
Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative MedicineFrancisco J Vizoso, Noemi Eiro, Sandra Cid, et al.
Journal of Neuroscience Research|September 26, 2008
1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatumBegoña Sanchez, Jose L Relova, Rosalia Gallego, et al.
Expert Opinion on Drug Discovery|February 3, 2018
Mouse models in squamous cell lung cancer: impact for drug discoveryAditi P Singh, Diego Adrianzen Herrera, Yifei Zhang, et al.
Lung Cancer Management|October 25, 2014
Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatmentHaiying Cheng, Marina Shcherba, Gopichand Pendurti, et al.
International Journal of Oncology|May 13, 2004
Exogenous expression of H-cadherin in CHO cells regulates contact inhibition of cell growth by inducing p21 expressionYun Zhong, Lluis Lopez-Barcons, Missak Haigentz, et al.
Expert Opinion on Emerging Drugs|January 6, 2015
Emerging drugs for squamous cell lung cancerHaiying Cheng, Marina Shcherba, Karthikeya Kandavelou, et al.
Pageof 14

Showing results (41-50 of 134) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|April 7, 2009
Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib; synergistic activity in human non-small cell lung cancer cell lines and xenograft modelsYi-He Ling, Miguel Aracil, José Jimeno, et al.
Clinical Lung Cancer|November 5, 2015
Toxicity and Pharmacokinetic Studies of Aerosolized Clinical Grade AzacitidineXuan Qiu, Yuanxin Liang, Rani S Sellers, et al.
Molecular Pharmacology|August 16, 2002
Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell linesYi-He Ling, Jian-Dong Jiang, James F Holland, et al.
Oncology (Williston Park, N.Y.)|December 25, 2007
Clinical presentation and pathophysiology of EGFRI dermatologic toxicitiesEdith P Mitchell, Roman Perez-Soler, Eric Van Cutsem, et al.
International Journal of Molecular Sciences|August 26, 2017
Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative MedicineFrancisco J Vizoso, Noemi Eiro, Sandra Cid, et al.
Journal of Neuroscience Research|September 26, 2008
1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatumBegoña Sanchez, Jose L Relova, Rosalia Gallego, et al.
Expert Opinion on Drug Discovery|February 3, 2018
Mouse models in squamous cell lung cancer: impact for drug discoveryAditi P Singh, Diego Adrianzen Herrera, Yifei Zhang, et al.
Lung Cancer Management|October 25, 2014
Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatmentHaiying Cheng, Marina Shcherba, Gopichand Pendurti, et al.
International Journal of Oncology|May 13, 2004
Exogenous expression of H-cadherin in CHO cells regulates contact inhibition of cell growth by inducing p21 expressionYun Zhong, Lluis Lopez-Barcons, Missak Haigentz, et al.
Expert Opinion on Emerging Drugs|January 6, 2015
Emerging drugs for squamous cell lung cancerHaiying Cheng, Marina Shcherba, Karthikeya Kandavelou, et al.
Pageof 14